Related Experiment Video
Updated: Nov 10, 2025

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish
Published on: May 5, 2021
Melatonin Improves Endoplasmic Reticulum Stress-Mediated IRE1α Pathway in Zücker Diabetic Fatty Rat
Samira Aouichat1,2, Miguel Navarro-Alarcon3, Pablo Alarcón-Guijo1
1Department of Pharmacology, Biohealth Institute and Neurosciences Institute, School of Medicine, University of Granada, 18016 Granada, Spain.
Abstract:
Obesity and diabetes are linked to an increased prevalence of kidney disease. Endoplasmic reticulum stress has recently gained growing importance in the pathogenesis of obesity and diabetes-related kidney disease. Melatonin, is an important anti-obesogenic natural bioactive compound. Previously, our research group showed that the renoprotective effect of melatonin administration was associated with restoring mitochondrial fission/fusion balance and function in a rat model of diabesity-induced kidney injury. This study was carried out to further investigate whether melatonin could suppress renal endoplasmic reticulum (ER) stress response and the downstream unfolded protein response activation under obese and diabetic conditions. Zücker diabetic fatty (ZDF) rats and lean littermates (ZL) were orally supplemented either with melatonin (10 mg/kg body weight (BW)/day) (M-ZDF and M-ZL) or vehicle (C-ZDF and C-ZL) for 17 weeks. Western blot analysis of ER stress-related markers and renal morphology were assessed. Compared to C-ZL rats, higher ER stress response associated with impaired renal morphology was observed in C-ZDF rats. Melatonin supplementation alleviated renal ER stress response in ZDF rats, by decreasing glucose-regulated protein 78 (GRP78), phosphoinositol-requiring enzyme1α (IRE1α), and ATF6 levels but had no effect on phospho-protein kinase RNA-like endoplasmic reticulum kinase (PERK) level. In addition, melatonin supplementation also restrained the ER stress-mediated apoptotic pathway, as indicated by decreased pro-apoptotic proteins phospho-c-jun amino terminal kinase (JNK), Bax, and cleaved caspase-3, as well as by upregulation of B cell lymphoma (Bcl)-2 protein. These improvements were associated with renal structural recovery. Taken together, our findings revealed that melatonin play a renoprotective role, at least in part, by suppressing ER stress and related pro-apoptotic IRE1α/JNK signaling pathway.
Insights
Melatonin, a natural compound, protects kidneys in diabetic rats by reducing endoplasmic reticulum (ER) stress and apoptosis. This study shows melatonin alleviates ER stress markers and improves kidney structure in diabetic conditions.
Area of Science:
- Nephrology
- Endocrinology
- Molecular Biology
Background:
- Obesity and diabetes significantly increase kidney disease prevalence.
- Endoplasmic reticulum (ER) stress is a key factor in diabetes-related kidney disease pathogenesis.
- Melatonin, an anti-obesogenic compound, previously showed renoprotective effects by restoring mitochondrial balance.
Purpose of the Study:
- To investigate if melatonin suppresses renal ER stress and unfolded protein response in obese, diabetic rats.
- To explore melatonin's impact on ER stress markers and apoptotic pathways in diabetic kidney injury.
Main Methods:
- Zücker diabetic fatty (ZDF) and lean (ZL) rats were supplemented with melatonin or vehicle for 17 weeks.
- Western blot analysis assessed ER stress markers (GRP78, IRE1α, ATF6, PERK) and apoptotic proteins (JNK, Bax, cleaved caspase-3, Bcl-2).
- Renal morphology was evaluated to assess structural changes.
Main Results:
- Diabetic ZDF rats exhibited higher ER stress and impaired renal morphology compared to lean ZL rats.
- Melatonin treatment reduced ER stress markers (GRP78, IRE1α, ATF6) and ER stress-mediated apoptosis (decreased JNK, Bax, cleaved caspase-3; increased Bcl-2) in ZDF rats.
- Melatonin supplementation led to renal structural recovery in ZDF rats.
Conclusions:
- Melatonin demonstrates a renoprotective role in diabetic kidney injury.
- Melatonin alleviates renal ER stress and inhibits the IRE1α/JNK apoptotic pathway.
- These findings suggest melatonin as a potential therapeutic agent for diabetic nephropathy.
More Related Videos
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025